Diastolic hypotension is an unrecognized risk factor for β-agonist-associated myocardial injury in children with asthma

Pediatric Critical Care Medicine

Volumn 14, Issue 6, 2013, Pages

  Sarnaik, Syana M ^a   Saladino, Richard A ^a   Manole, Mioara ^a   Pitetti, Raymond A ^a   Arora, Gaurav ^a   Kuch, Bradley A ^b   Orr, Richard A ^b   Felmet, Kathryn A ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

agonist associated myocardial injury; Albuterol toxicity; Diastolic hypotension

Indexed keywords

ADRENALIN; AMINOPHYLLINE; HELIOX; MAGNESIUM SULFATE; SALBUTAMOL; TERBUTALINE; TROPONIN;

ARTICLE; ASTHMA; ASTHMATIC STATE; CHILD; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIASTOLIC HYPOTENSION; DISEASE ASSOCIATION; DRUG MEGADOSE; ENDOTRACHEAL INTUBATION; HEART MUSCLE INJURY; HEART RATE; HIGH RISK PATIENT; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA;

EID: 84880768392     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e31828a7677     Document Type: Article

References (28)

1. Zanoni LZ, Palhares DB, Consolo LC: Myocardial ischemia induced by nebulized fenoterol for severe childhood asthma. Indian Pediatr 2005; 42: 1013-1018
2. Maguire JF, O'Rourke PP, Colan SD, et al: Cardiotoxicity during treatment of severe childhood asthma. Pediatrics 1991; 88: 1180-1186
3. Chiang VW, Burns JP, Rifai N, et al: Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: A prospective assessment. J Pediatr 2000; 137: 73-77
4. Raper R, Fisher M, Bihari D: Profound, reversible, myocardial depression in acute asthma treated with high-dose catecholamines. Crit Care Med 1992; 20: 710-712
5. Drislane FW, Samuels MA, Kozakewich H, et al: Myocardial contraction band lesions in patients with fatal asthma: Possible neurocardiologic mechanisms. Am Rev Respir Dis 1987; 135: 498-501
6. Kurland G, Williams J, Lewiston NJ: Fatal myocardial toxicity during continuous infusion intravenous isoproterenol therapy of asthma. J Allergy Clin Immunol 1979; 63: 407-411
7. Papo MC, Frank J, Thompson AE: A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993; 21: 1479-1486
8. Katz RW, Kelly HW, Crowley MR, et al: Safety of continuous nebulized albuterol for bronchospasm in infants and children. Pediatrics 1993; 92: 666-669
9. Craig VL, Bigos D, Brilli RJ: Efficacy and safety of continuous albuterol nebulization in children with severe status asthmaticus. Pediatr Emerg Care 1996; 12: 1-5
10. Taşar MA, Bostanci I, Atli O, et al: Effect of short-acting inhaler beta2- agonists on serum cardiac troponin in wheezy infant. Allergy Asthma Proc 2005; 26: 477-482
11. National Heart, Lung, and Blood Institute: Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD, National Heart, Lung, and Blood Institute, 2007, p 386
12. Johnson M: The beta-adrenoceptor. Am J Respir Crit Care Med 1998; 158(5, Part 3): S146-S153
13. National Heart Lung and Blood Institute's Task Force on Blood Pressure Control in Children: Report of the task force on blood pressure control in children. Pediatrics 1977; 59: 797-820
14. Kanaan UB, Chiang VW: Cardiac troponins in pediatrics. Pediatr Emerg Care 2004; 20: 323-329
15. Hirsch R, Landt Y, Porter S, et al: Cardiac troponin I in pediatrics: Normal values and potential use in the assessment of cardiac injury. J Pediatr 1997; 130: 872-877
16. Bogie AL, Towne D, Luckett PM, et al: Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus. Pediatr Emerg Care 2007; 23: 355-361
17. Kim IK, Saville AL, Sikes KL, et al: Heliox-driven albuterol nebulization for asthma exacerbations: An overview. Respir Care 2006; 51: 613-618
18. Wildhaber JH, Dore ND, Wilson JM, et al: Inhalation therapy in asthma: Nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J Pediatr 1999; 135: 28-33
19. Robinson RB: Autonomic receptor-effector coupling during postnatal development. Cardiovasc Res 1996; 31 Spec No: E68-E76
20. Hein TW, Zhang C, Wang W, et al: Heterogeneous beta2-adrenoceptor expression and dilation in coronary arterioles across the left ventricular wall. Circulation 2004; 110: 2708-2712
21. Fokkema DS, VanTeeffelen JW, Dekker S, et al: Diastolic time fraction as a determinant of subendocardial perfusion. Am J Physiol Heart Circ Physiol 2005; 288: H2450-H2456
22. Canty JM Jr, Giglia J, Kandath D: Effect of tachycardia on regional function and transmural myocardial perfusion during graded coronary pressure reduction in conscious dogs. Circulation 1990; 82: 1815-1825
23. Pinsky MR: Cardiovascular issues in respiratory care. Chest 2005; 128(5 Suppl 2): 592S-597S
24. Krishnan V, Diette GB, Rand CS, et al: Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med 2006; 174: 633-638
25. Huovinen E, Kaprio J, Vesterinen E, et al: Mortality of adults with asthma: A prospective cohort study. Thorax 1997; 52: 49-54
26. de Marco R, Locatelli F, Cazzoletti L, et al: Incidence of asthma and mortality in a cohort of young adults: A 7-year prospective study. Respir Res 2005; 6: 95
27. Nelson HS, Weiss ST, Bleecker ER, et al; SMART Study Group: The Salmeterol Multicenter Asthma Research Trial: A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129: 15-26
28. Sears MR: Adverse effects of beta-agonists. J Allergy Clin Immunol 2002; 110(6 Suppl): S322-S328